Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 5613056, 11 pages
http://dx.doi.org/10.1155/2016/5613056
Research Article

Cardiorenal Involvement in Metabolic Syndrome Induced by Cola Drinking in Rats: Proinflammatory Cytokines and Impaired Antioxidative Protection

1Institute of Cardiological Research, University of Buenos Aires, National Research Council (ININCA, UBA, CONICET), 1122 Buenos Aires, Argentina
2University of Perugia School of Medicine, 06132 Perugia, Italy

Received 9 December 2015; Revised 21 March 2016; Accepted 10 April 2016

Academic Editor: Aaron L. Sverdlov

Copyright © 2016 Matilde Otero-Losada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Milei, M. O. Losada, H. G. Llambí et al., “Chronic cola drinking induces metabolic and cardiac alterations in rats,” World Journal of Cardiology, vol. 3, no. 4, pp. 111–116, 2011. View at Publisher · View at Google Scholar
  2. M. E. Otero-Losada, D. R. Grana, A. Müller, G. Ottaviano, G. Ambrosio, and J. Milei, “Lipid profile and plasma antioxidant status in sweet carbonated beverage-induced metabolic syndrome in rat,” International Journal of Cardiology, vol. 146, no. 1, pp. 106–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Otero-Losada, G. Cao, J. González et al., “Functional and morphological changes in endocrine pancreas following cola drink consumption in rats,” PLoS ONE, vol. 10, no. 3, Article ID e0118700, 2015. View at Publisher · View at Google Scholar
  4. F. Locatelli, P. Pozzoni, and L. Del Vecchio, “Renal manifestations in the metabolic syndrome,” Journal of the American Society of Nephrology, vol. 17, no. 2, pp. S81–S85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Ronco, M. Haapio, A. A. House, N. Anavekar, and R. Bellomo, “Cardiorenal syndrome,” Journal of the American College of Cardiology, vol. 52, no. 19, pp. 1527–1539, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Canadian Council on Animal Care, Guide to the Care and Use of Experimental Animals, vol. 2, Canadian Council on Animal Care, Ottawa, Canada, 2nd edition, 1993, http://www.ccac.ca/Documents/Standards/Guidelines/Experimental_Animals_Vol1.pdf.
  7. A. Kaplan, R. Jack, K. E. Opheim, B. Toivola, and A. W. Lyon, Clinical Chemistry: Interpretation and Techniques, Williams & Wilkins, Philadelphia, Pa, USA, 4th edition, 1995.
  8. J. Karpińska, B. Mikołuć, R. Motkowski, and J. Piotrowska-Jastrzebska, “HPLC method for simultaneous determination of retinol, α-tocopherol and coenzyme Q10 in human plasma,” Journal of Pharmaceutical and Biomedical Analysis, vol. 42, no. 2, pp. 232–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. D. Crowley, M. P. Vasievich, P. Ruiz et al., “Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis,” Journal of Clinical Investigation, vol. 119, no. 4, pp. 943–953, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. E. Pagtalunan, J. A. Drachman, and T. W. Meyer, “Methods for estimating the volume of individual glomeruli,” Kidney International, vol. 57, no. 6, pp. 2644–2649, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Tolins and L. Raij, “Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomemlar injury,” Hypertension, vol. 16, no. 4, pp. 452–461, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-G. Wu, Y.-L. Chang, J.-W. Lin et al., “Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction,” PLoS ONE, vol. 6, no. 8, Article ID e23303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. V. Miles, J. A. Morrison, P. S. Horn, P. H. Tang, and A. J. Pesce, “Coenzyme Q10 changes are associated with metabolic syndrome,” Clinica Chimica Acta, vol. 344, no. 1-2, pp. 173–179, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Holvoet, “Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease,” Verhandelingen—Koninklijke Academie voor Geneeskunde van België, vol. 70, no. 3, pp. 193–219, 2008. View at Google Scholar
  15. A. Asmar, L. Simonsen, M. Asmar et al., “Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men,” American Journal of Physiology—Endocrinology and Metabolism, vol. 308, no. 8, pp. E641–E649, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. E. J. Whalen, A. K. Johnson, and S. J. Lewis, “Hemodynamic responses elicited by systemic injections of isotonic and hypertonic saline in hemorrhaged rats,” Microvascular Research, vol. 91, pp. 22–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. D. M. Colquhoun, R. Jackson, M. Walters et al., “Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans,” European Journal of Clinical Investigation, vol. 35, no. 4, pp. 251–258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. McLachlan, E. Beattie, M. P. Murphy et al., “Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular function,” Journal of Hypertension, vol. 32, no. 3, pp. 555–564, 2014. View at Publisher · View at Google Scholar
  19. A. Heidland, K. Sebekova, and R. Schinzel, “Advanced glycation end products and the progressive course of renal disease,” American Journal of Kidney Diseases, vol. 38, no. 4, pp. S100–S106, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. K. P. Klausen, H.-H. Parving, H. Scharling, and J. S. Jensen, “The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality,” Journal of Internal Medicine, vol. 262, no. 4, pp. 470–478, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Viggiano and R. Pollastro, “Relation among Blood Pressure,” Heart Rate and Creatinine in Kidney Transplanted Patients. Insights in Blood Pressure, vol. 1, article 3, 2015. View at Google Scholar
  22. J. F. E. Mann, “Cardiovascular risk in patients with mild renal insufficiency: implications for the use of ACE inhibitors,” Presse Medicale, vol. 34, no. 18, pp. 1303–1308, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Celec, R. Pálffy, R. Gardlík et al., “Renal and metabolic effects of three months of decarbonated cola beverages in rats,” Experimental Biology and Medicine, vol. 235, no. 11, pp. 1321–1327, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Trevisan, A. R. Dodesini, and G. Lepore, “Lipids and renal disease,” Journal of the American Society of Nephrology, vol. 17, no. 2, pp. S145–S147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Shao, X. Lu, W. Cong et al., “Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress,” PLoS ONE, vol. 9, no. 3, Article ID e92574, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Vlassara, M. Torreggiani, J. B. Post, F. Zheng, J. Uribarri, and G. E. Striker, “Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging,” Kidney International, vol. 114, pp. S3–S11, 2009. View at Google Scholar · View at Scopus
  27. K. van der Putten, L. G. Bongartz, B. Braam, and C. A. Gaillard, “The cardiorenal syndrome a classification into 4 groups?” Journal of the American College of Cardiology, vol. 53, no. 15, pp. 1339–1342, 2009. View at Google Scholar
  28. G. Li Cavoli, R. Passantino, A. Ferrantelli et al., “Acute kidney injury in a patient with metabolic syndrome,” BioImpacts, vol. 5, no. 3, pp. 155–157, 2015. View at Publisher · View at Google Scholar · View at Scopus